These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 35563313)
1. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status. Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313 [TBL] [Abstract][Full Text] [Related]
2. The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status. Pustovalova M; Alhaddad L; Blokhina T; Smetanina N; Chigasova A; Chuprov-Netochin R; Eremin P; Gilmutdinova I; Osipov AN; Leonov S Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673439 [TBL] [Abstract][Full Text] [Related]
3. The p53-53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure. Pustovalova M; Alhaddad L; Smetanina N; Chigasova A; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397297 [TBL] [Abstract][Full Text] [Related]
4. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918 [TBL] [Abstract][Full Text] [Related]
5. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling. Su J; Wu S; Wu H; Li L; Guo T Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583 [TBL] [Abstract][Full Text] [Related]
6. CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Desai A; Webb B; Gerson SL Radiother Oncol; 2014 Mar; 110(3):538-45. PubMed ID: 24440048 [TBL] [Abstract][Full Text] [Related]
7. Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status. Alhaddad L; Chuprov-Netochin R; Pustovalova M; Osipov AN; Leonov S Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674747 [TBL] [Abstract][Full Text] [Related]
8. IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Chen Y; Zhang F; Tsai Y; Yang X; Yang L; Duan S; Wang X; Keng P; Lee SO Radiat Oncol; 2015 Nov; 10():227. PubMed ID: 26572130 [TBL] [Abstract][Full Text] [Related]
9. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ PLoS One; 2013; 8(1):e54193. PubMed ID: 23349823 [TBL] [Abstract][Full Text] [Related]
10. CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. Roudi R; Madjd Z; Ebrahimi M; Samani FS; Samadikuchaksaraei A Cell Mol Biol Lett; 2014 Mar; 19(1):23-36. PubMed ID: 24363164 [TBL] [Abstract][Full Text] [Related]
11. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549. Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
13. BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression. Jiang P; Li F; Liu Z; Hao S; Gao J; Li S Respir Res; 2021 Dec; 22(1):320. PubMed ID: 34949193 [TBL] [Abstract][Full Text] [Related]
14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
15. Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cells. Eroglu Z; Erdem C; Oktem G; Bozok Cetintas V; Duzgun Z Mol Med Rep; 2020 Jul; 22(1):575-581. PubMed ID: 32377734 [TBL] [Abstract][Full Text] [Related]
16. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462 [TBL] [Abstract][Full Text] [Related]
17. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
18. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest. Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278 [TBL] [Abstract][Full Text] [Related]
19. IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression. Alhaddad L; Pustovalova M; Blokhina T; Chuprov-Netochin R; Osipov AN; Leonov S Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071477 [TBL] [Abstract][Full Text] [Related]
20. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer. Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]